Mental Health Disparities Seen Among Sexual, Gender Minority Populations

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 4, 2025.

By Lori Solomon HealthDay Reporter

TUESDAY, Feb. 4, 2025 -- There are significant mental health disparities between sexual and gender minority (SGM) populations and cisgender heterosexual populations (non-SGM), according to a study published online Jan. 29 in JAMA Network Open.

Junjie Anderson Lu, M.D., from Stanford University in California, and colleagues explored mental health disparities between SGM and non-SGM populations across sexual orientation, sex assigned at birth, and gender identity. The analysis included data from 413,457 participants in the All of Us Research Program.

The researchers found that men with cisgender sexual minority identity had higher odds of bipolar disorder (adjusted odds ratio [aOR], 1.87) compared with cisgender heterosexual men, while women with cisgender sexual minority identity had higher odds of bipolar disorder (aOR, 2.09) versus cisgender heterosexual women. There were higher odds of posttraumatic stress disorder among gender-diverse people assigned female sex at birth versus both cisgender heterosexual men (aOR, 3.67) and cisgender heterosexual women (aOR, 2.77). Among gender-diverse individuals assigned male sex at birth, there were higher odds of bipolar disorder (aOR, 2.35) versus cisgender heterosexual men and higher odds of attention-deficit/hyperactivity disorder (aOR, 2.19) versus cisgender heterosexual women. Higher odds of depression were seen among transgender men (aOR, 2.11) versus cisgender heterosexual men. Transgender women had higher odds of any personality disorder (aOR, 2.71) versus cisgender heterosexual women.

"These findings underscore the need for tailored mental health interventions to improve the well-being of SGM populations, while noting that the associations do not imply causality but reflect the stigma and minority stress experienced by these individuals," the authors write.

One author disclosed ties to Hims and Hers Health, FOLX Health, and Otsuka Pharmaceutical.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-02-05 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords